Stock listing

Swedish Orphan Biovitrum Ab

Selected listing: B6E · SWB · EUR · DE

Swedish Orphan Biovitrum Ab (Stuttgart:B6E), Health Technology. Latest release Sep 30, 2026: Change in number of shares and votes in Sobi.

B6E:SWBEURDEUpdated October 3, 2026

Ticker: Stuttgart:B6E
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Stuttgart
Currency: EUR

About Swedish Orphan Biovitrum Ab

Swedish Orphan Biovitrum Ab (SOBI) is a public company based in Sweden, specializing in the development and commercialization of innovative therapies for rare diseases. The company is committed to improving the quality of life for patients through its specialized products and services.

Latest news from Swedish Orphan Biovitrum Ab

Change in number of shares and votes in Sobi

September 30, 2026

Swedish Orphan Biovitrum : Sobi and Innate announce partnership is now effective following completion of closing conditions

September 16, 2026

Sobi and Innate announce partnership is now effective following completion of closing conditions

September 15, 2026

Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome

September 9, 2026

Sobi has completed an issue of class C shares

August 31, 2026

All Swedish Orphan Biovitrum Ab news →

Events

Replays

Swedish Orphan Biovitrum AB (SOBI) Q2 2026 Earnings Call
Thu, Jul 16, 2026 · 08:00 AM ET
Watch
Swedish Orphan Biovitrum AB (SOBI) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 06:30 AM ET
Watch
Swedish Orphan Biovitrum AB (SOBI) Q4 2025 Earnings Call
Thu, Feb 05, 2026 · 02:00 AM ET
Watch

Research Swedish Orphan Biovitrum Ab

Swedish Orphan Biovitrum Ab company profile

View the public company page for Swedish Orphan Biovitrum Ab on 6ix.

Swedish Orphan Biovitrum Ab news

Read company news and market updates connected to Swedish Orphan Biovitrum Ab.

Swedish Orphan Biovitrum Ab investor events

Find investor webinars, events, and replay context for Swedish Orphan Biovitrum Ab.